Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e583-e585. doi: 10.1111/jdv.16451. Epub 2020 May 19.

Authors

N Hornick¹, A Wang¹, Y Lim¹, J Gehlhausen¹, J Siegel¹, J Wang¹, F Foss^{1

2}, I Lim¹, A Zubek¹, L Milstone¹, A Galan^{1

3}, B King¹, W Damsky¹

Affiliations

¹ Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
² Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
³ Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

PMID: 32277505
DOI: 10.1111/jdv.16451

No abstract available

Publication types

Letter

MeSH terms

Humans
Interleukin-17
Psoriasis* / drug therapy
Sarcoidosis* / chemically induced

Substances

Interleukin-17

Grants and funding